Skip to content
Advertisement

Tempus operates CLIA-certified genomic sequencing labs and has built a library of more than 8.5 million de-identified patient records, including over 1.5 million linking clinical and genomic data, which it licenses alongside its diagnostics to life-sciences and provider partners. Tempus is publicly traded (Nasdaq: TEM).

Multimodal
Advertisement